Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.

Posted on June 2, 2008 in Prescriptions (Category: Default)

AIDS November 2007

\"Circumstances: These observations challenge the current regard of HIV-1 turnover as well compartmentalization. They furthermore aim the warrant of this new integrase inhibitor raltegravir.\"

Original article: Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.

Tags: , , , ,

Search